oxy-wt: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Million (M) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net income	2,255	1,413	945	3,198
Discontinued operations, net	0	0	0	182
Depreciation, depletion and amortization of assets	5,914	3,853	1,917	5,394
Deferred income tax provision (benefit)	1	-146	-129	-182
Asset impairments and related items	0	-	-	21
(gains) losses on sales of assets and other, net	13	-21	-	-52
Other noncash charges to income	-685	-502	-267	-339
(increase) decrease in trade receivables	-352	-55	85	532
(increase) decrease in inventories	-16	-243	49	226
(increase) decrease in other current assets	76	-27	52	-219
Decrease in accounts payable and accrued liabilities	-1,067	-622	-686	-430
Increase (decrease) in current domestic and foreign income taxes	-169	-238	20	512
Operating cash flow from continuing operations	7,898	-	-	8,183
Operating cash flow from discontinued operations, net of taxes	0	-	-	-100
Net cash provided by operating activities	7,898	5,108	2,148	8,083
Capital expenditures	5,674	3,906	1,908	5,237
Change in capital accrual	-87	-7	5	-39
Purchases of assets, businesses and equity investments, net	231	108	52	9,037
Proceeds from sales of assets and equity investments, net	-	-	1,306	1,662
Proceeds from sales of assets, net	2,230	1,450	-	-
Equity investments and other, net	227	159	82	149
Net cash used by investing activities	-3,989	-2,730	-731	-12,800
Draws on receivables securitization facility	-	-	-	0
Payment of receivables securitization facility	-	-	-	0
Proceeds from long-term debt, net	0	-	-	9,612
Payments of long-term debt, net	3,584	2,280	518	4,007
Proceeds from issuance of common stock	948	931	25	571
Redemption of preferred stock	-	-	-	0
Purchases of treasury stock	0	0	-	9
Cash dividends paid on common and preferred stock	1,186	778	380	1,069
Contributions from noncontrolling interest	153	114	63	146
Payment for taxes related to stock-based award settlement	63	-	-	103
Other financing, net	-138	-162	-122	-95
Net cash provided (used) by financing activities	-3,870	-2,175	-932	5,046
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents	39	203	485	329
Cash and cash equivalents at beginning of period	2,157	2,157	2,157	1,464
Cash and cash equivalents at end of period	2,196	2,360	2,642	1,793

Unit: Million (M) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

oxy-wt: the cashflow